Product Information

KETOROLAC 10 MG TABLET is a generic product labeled by Leading Pharma, LLC, priced at $0.1703 per EA under NDC 69315026001. Its NADAC has been published 124 times since Jul 3, 2024.

FDA first approved this application on Feb 23, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

KETOROLAC 10 MG TABLET

KETOROLAC TROMETHAMINE
$0.1703per EA

Strength

10 mg/1

NDC

69315026001

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

KETOROLAC TROMETHAMINE

Approval Type

Generic (ANDA)

FDA Application

ANDA215745

FDA Approved

2/23/2023

TE Code

AB

On Market Since

3/1/2024

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitor
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for KETOROLAC 10 MG TABLET has been published 124 times since Jul 3, 2024, and over the history we have for it it has declined 59.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1703 per EA
All-time high$0.4224 (Jul 10, 2024)
All-time low$0.1244 (Mar 18, 2026)
52-week high$0.1764
52-week low$0.1244
Median price$0.2502
Average price$0.2404
Largest weekly change-31.6% (Nov 20, 2024)
Weeks tracked124
Tracking sinceJul 3, 2024

Price History

1W

0.0%

1M

+3.5%

3M

+2.7%

6M

+7.3%

1Y

-22.7%

3Y

N/A

5Y

N/A

All

-59.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the KETOROLAC TROMETHAMINE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of KETOROLAC 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 10 MG TABLET, manufactured by Leading Pharma, LLC, is $0.1703 per EA (NDC 69315026001), effective Nov 11, 2026.

How has the price of KETOROLAC 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for KETOROLAC 10 MG TABLET has declined 59.7%. It has been tracked across 124 weekly CMS publications since Jul 3, 2024.

What are the highest and lowest recorded NADAC prices for KETOROLAC 10 MG TABLET?

Since Jul 3, 2024, the NADAC for KETOROLAC 10 MG TABLET has ranged from a low of $0.1244 (Mar 18, 2026) to a high of $0.4224 (Jul 10, 2024), with a median of $0.2502 per EA.

Are there cheaper alternatives to KETOROLAC 10 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of KETOROLAC 10 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures KETOROLAC 10 MG TABLET?

KETOROLAC 10 MG TABLET (NDC 69315026001) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.